AVIGEN INC \DE (AVGN) is a publicly traded company in the Unknown sector. Across all available filings, 18 corporate insiders have executed 130 transactions totaling $7.9M, demonstrating a bullish sentiment with $4.3M in net insider flow. The most recent transaction on Dec 18, 2009 involved a transaction of 4,884,508 shares valued at $0.
No significant insider buying has been recorded for AVGN in the recent period.
No significant insider selling has been recorded for AVGN in the recent period.
Based on recent SEC filings, insider sentiment for AVGN is bullish with an Insider Alignment Score of 77/100 and a net flow of $4.3M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
Insider trading at AVIGEN INC \DE (AVGN) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 18 insiders are actively trading AVGN stock, having executed 130 transactions in the past 90 days. The most active insider is Asset Management, Llc Burlingame (Executive), who has made 9 transactions totaling $3.3M.
Get notified when executives and directors at AVGN file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Dec 18, 2009 | Opportunity Master Fund, L.p. Southpaw Credit | Executive | Tender | 4,884,508 | $N/A | $0 | |
| Dec 18, 2009 | K. A. Prendergast John | Executive | Disposition | 39,108 | $N/A | $0 | |
| Dec 18, 2009 | August Sauter Andrew | Executive | Disposition | 4,125 | $N/A | $0 | |
| Dec 16, 2009 | Management, Llc Burlingame Asset | Executive | Sale | 181,526 | $1.30 | $236.0K | |
| Dec 16, 2009 | Management, Llc Burlingame Asset | Executive | Purchase | 14,159 | $1.33 | $18.8K | |
| Dec 15, 2009 | Management, Llc Burlingame Asset | Executive | Purchase | 167,367 | $1.32 | $220.9K | |
| Dec 14, 2009 | Management, Llc Burlingame Asset | Executive | Purchase | 1,280,203 | $1.35 | $1.7M | Large |
| Nov 19, 2009 | P. Horovitz Zola | Executive | Sale | 5,000 | $1.43 | $7.2K | |
| Nov 18, 2009 | N. Lampert Mark | Executive | Sale | 626 | $1.50 | $939 | |
| Oct 29, 2009 | Management, Llc Burlingame Asset | Executive | Purchase | 2,000 | $1.47 | $2.9K | |
| Oct 28, 2009 | Management, Llc Burlingame Asset | Executive | Purchase | 6,435 | $1.48 | $9.5K | |
| Oct 21, 2009 | Fund II Lp Biotechnology Value | Executive | Sale | 277,000 | $1.50 | $415.5K | |
| Oct 21, 2009 | Fund II Lp Biotechnology Value | Executive | Sale | 80,000 | $1.50 | $120.0K | |
| Oct 21, 2009 | Fund II Lp Biotechnology Value | Executive | Sale | 115,200 | $1.50 | $172.8K | |
| Oct 21, 2009 | Golden Howard | Executive | Purchase | 459,490 | $1.53 | $703.0K | Large |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Purchase(P) | 55 | $6.1M | 76.1% |
Sale(S) | 58 | $1.8M | 22.4% |
Exercise(M) | 10 | $118.6K | 1.5% |
Tender(U) | 1 | $0 | 0.0% |
Disposition(D) | 2 | $0 | 0.0% |
Gift(G) | 4 | $0 | 0.0% |
Insiders at AVIGEN INC \DE are accumulating shares at an accelerated pace. With 18 insiders making 130 transactions totaling $6.1M in purchases versus $1.8M in sales, the net buying activity of $4.3M signals strong executive confidence. Asset Management, Llc Burlingame (Executive) leads the buying activity with $3.3M in transactions across all time.